Not intended for US and UK audiences BI 765423 has been developed to target IL-11, a key driver of fibrosis…
January 13, 2026 07:05 ET | Source: Sight Sciences, Inc. MENLO PARK, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Sight…
January 13, 2026 07:05 ET | Source: Treace Medical Concepts, Inc. PONTE VEDRA, Fla., Jan. 13, 2026 (GLOBE NEWSWIRE) --…
Approval is supported by data from the DEVOTE study which showed the benefit of the SPINRAZA 50 mg and 28…
January 12, 2026 10:30 ET | Source: BridgeBio Pharma, Inc. - Preliminary unaudited Q4 and Full Year 2025 net Attruby® product…
Knoxville, TN, Jan. 12, 2026 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation (OTCID: SSGC), a leading AI technology company delivering multimodal…
January 11, 2026 13:00 ET | Source: Krystal Biotech, Inc. Preliminary 4Q 2025 VYJUVEK net revenue of $106 million to…
January 11, 2026 09:30 ET | Source: RxSight, Inc. ALISO VIEJO, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: RXST)…
• Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at month-24 post-treatment Patient 1 continued…
CENTERVILLE, Utah, Jan. 10, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only and doesn't constitute medical…